BioCentury
ARTICLE | Clinical News

ABX-A regulatory update

May 19, 2014 7:00 AM UTC

Abeona said FDA granted Orphan Drug designation to ABX-A to treat mucopolysaccharidosis IIIA (MPS IIIA, Sanfilippo A syndrome) and to ABX-B to treat mucopolysaccharidosis IIIB (MPS IIIB, Sanfilippo B...